News
-
-
-
-
-
REGULATED PRESS RELEASE
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
Biophytis obtains FDA approval to start phase 2 OBA study in obesity with BIO101 (20-hydroxyecdysone), focusing on muscle strength improvement. Study led by Prof. Marc-André Cornier to start mid-2024 in the USA -
-
-
-
-
PRESS RELEASE
Final Bell Holdings International Announces Revocation of Cease Trade Order and Closing of First Tranche of a US$12,000,000 Note Financing
Final Bell Holdings International Ltd. lifts cease trade order and closes first tranche of US$12 million convertible notes offering through subsidiary FBI for expansion in the United States